US IPO market sees resurgence in 2025 led by tech deals

The US IPO market rebounded in 2025 with 336 offerings through mid-December, a 55% rise from 216 in the same period of 2024, led by technology and fintech deals and supported by higher liquidity and selective monetary easing. Notable listings include CoreWeave (priced $40, sold 37.5m shares, raised $1.5bn, $23bn IPO valuation, market cap ~$34.4bn and a $55.6bn backlog), Circle (priced $31, 34m shares, $1.05bn raised, full greenshoe to $1.2bn; peak intraday to $103.75), Chime (priced $27, 32m shares, $864m raised, $11.6bn FDV), Figma (priced $33, +250% debut), and Klarna (34.3m shares at $35–$37, up to $1.27bn raised, near $20bn market value on debut). The momentum sets up a heavy 2026 pipeline with potential mega-listings (SpaceX, Stripe, Databricks, Revolut, Kraken, Canva) that could reallocate private-market capital and influence public market flows.

Analysis

Market structure: The 55% y/y jump to 336 US IPOs through mid‑Dec signals meaningful supply re-entry from private markets, benefiting exchanges (NDAQ), underwriters, custody/cloud infra (CRWV) and fintech rails (CRCL, CHYM, KLAR) who capture fee and client flows. Increased primary issuance alongside Q3 equity strength implies short‑term demand > supply, but rising high‑beta float risks quicker mean reversion; expect elevated equity turnover, wider options IV and compressed investment‑grade spreads as portfolio cash rotates into IPOs.

Risk assessment: Key tail risks are regulatory shocks to fintech/crypto (Circle, Kraken) or AI export/data rules that could wipe >30% off specialized infra providers in weeks; a liquidity reversal (Fed tightening or stopped easing) could trigger a >15% drawdown in high‑growth IPO cohorts within 3 months. Hidden dependency: several winners rely on concentrated customers (CoreWeave: Meta/OpenAI) and large lock‑up expiries (6 months) create predictable supply shocks. Catalysts: Fed minutes, lock‑up calendars, and SpaceX/Stripe filing dates will accelerate flows.

Trade implications: Tactical trades should favor exchange/fee beneficiaries and resilient infra: overweight NDAQ and CRWV (12‑month horizon), underweight frothy debutants post‑pop. Use options to monetize elevated IV — sell covered calls on CRCL and buy 3–6 month 5% OTM puts on QQQ as portfolio tail insurance. Pair trades: long ADBE vs short FIG to capture reversion if Figma’s 250% pop proves transient; size 1–2% each, horizon 3–9 months.

Contrarian angles: Consensus underestimates secondary‑market overhang and customer concentration; many unicorns priced on S‑1 narratives not repeatable revenue (watch backlog conversion rates). Historical parallel: 2000 tech IPO froth showed rapid 100%+ first‑day pops then multi‑quarter mean reversion — fade extreme debut moves after 1–3 months unless consistent top‑line beat and diversified customer base.

Key Decisions for Investors

• Establish a 2–3% long position in CRWV within 30 days (Nasdaq: CRWV); target a 12‑month upside to a $50B market cap (~+45% from $34.4B) if backlog converts, place a stop at -25%.
• Initiate a 2% long position in NDAQ (Nasdaq: NDAQ) for 6–12 month horizon to capture IPO fee tailwinds; target +15–25% and set an initial stop at -15%.
• Execute a 1–2% pair trade: short FIG (NYSE: FIG) and long ADBE (NASDAQ: ADBE) equal dollar size for 3–9 months to capture potential post‑pop reversion; cut if FIG outperforms ADBE by >30%.
• Sell covered calls on high‑vol IPO winners (e.g., CRCL) to harvest premium: sell 3‑month calls at 1.2x current price and simultaneously buy 6‑month 10% OTM puts on QQQ sized to hedge 1–2% portfolio risk.
• Actively monitor lock‑up expiry calendars and Fed communications over next 90 days: if any issuer’s float increases >10% within a 30‑day window, reduce position in that issuer by 50% and reassess liquidity needs.